Peter Friedmann to Hepatitis C, Chronic
This is a "connection" page, showing publications Peter Friedmann has written about Hepatitis C, Chronic.
Connection Strength
1.566
-
Friedmann PD, Wilson D, de Gijsel D, Nolte K, Dejace J, Hoskinson R, Del Toro-Mejias L, Bianchet E, Dowd P, Soares WE, Stopka TJ. Mobile Telemedicine for Treating Chronic Hepatitis C Among Rural People Who Inject Drugs: A Randomized Clinical Trial. JAMA Netw Open. 2026 Jan 02; 9(1):e2555125.
Score: 0.883
-
Cioe PA, Stein MD, Promrat K, Friedmann PD. A comparison of modified directly observed therapy to standard care for chronic hepatitis C. J Community Health. 2013 Aug; 38(4):679-84.
Score: 0.373
-
Nolte K, Del Toro-Mejias L, Bianchet E, Tarplin S, Hoskinson R, Friedmann PD, Stopka TJ. Convenience, rapport and skill: effective rural hepatitis C treatment, qualitative findings from a mobile harm reduction-informed tele-medicine intervention in Northern New England, 2022-2024. Harm Reduct J. 2026 02 25; 23(1).
Score: 0.223
-
Taylor LE, Maynard MA, Friedmann PD, Macleod CJ, Rich JD, Flanigan TP, Sylvestre DL. Buprenorphine for human immunodeficiency virus/hepatitis C virus-coinfected patients: does it serve as a bridge to hepatitis C virus therapy? J Addict Med. 2012 Sep; 6(3):179-85.
Score: 0.088